Clinical Trial Update: Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of lusutrombopag and recombinant human thrombopoietin for thrombocytopenia in patients with chronic liver di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Thrombocytopenia

Drugs mentioned

• lusutrombopag (lusutrombopag)
• recombinant human thrombopoietin (recombinant human thrombopoietin)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Thrombocytopenia | Phase 2 | Status: RECRUITING